Report

Global 3D Printed Drugs Market Size study, by Technology, By Application, By End-use and Regional Forecasts 2022-2028

  • Publish Date: Oct,2022
  • Report ID: QI037
  • Page : 200
  • Report Type : PDF (Email)
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. 3D Printed Drugs Market, by Region, 2020-2028 (USD Million)
1.2.2. 3D Printed Drugs Market, by Technology,2020-2028 (USD Million)
1.2.3. 3D Printed Drugs Market, by Application,2020-2028 (USD Million)
1.2.4. 3D Printed Drugs Market, by End-use,2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global 3D Printed Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global 3D Printed Drugs Market Dynamics
3.1. 3D Printed Drugs Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising Usage Of 3D Printing in The Medical Industries
3.1.1.2. Increasing Adoption of Personalized Drugs
3.1.2. Market Challenges
3.1.2.1. Lack Of Government Regulations for 3D Printed Products
3.1.3. Market Opportunities
3.1.3.1. High Demand for Instantaneous Soluble Tablets
Chapter 4. Global 3D Printed Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global 3D Printed Drugs Market, by Technology
6.1. Market Snapshot
6.2. Global 3D Printed Drugs Market by Technology, Performance - Potential Analysis
6.3. Global 3D Printed Drugs Market Estimates & Forecasts by Technology,2018-2028 (USD Million)
6.4. 3D Printed Drugs Market, Sub Segment Analysis
6.4.1. Inkjet Printing
6.4.2. Fused Deposition Modeling
6.4.3. Stereolithography
6.4.4. ZipDose Technology
Chapter 7. Global 3D Printed Drugs Market, by Application
7.1. Market Snapshot
7.2. Global 3D Printed Drugs Market by Application, Performance - Potential Analysis
7.3. Global 3D Printed Drugs Market Estimates & Forecasts by Application,2018-2028 (USD Million)
7.4. 3D Printed Drugs Market, Sub Segment Analysis
7.4.1. Orthopedic
7.4.2. Neurology
7.4.3. Dental
7.4.4. Others
Chapter 8. Global 3D Printed Drugs Market, by End-use
8.1. Market Snapshot
8.2. Global 3D Printed Drugs Market by End-use, Performance - Potential Analysis
8.3. Global 3D Printed Drugs Market Estimates & Forecasts by End-use,2018-2028 (USD Million)
8.4. 3D Printed Drugs Market, Sub Segment Analysis
8.4.1. Hospitals & clinics
8.4.2. Research Laboratories
8.4.3. Others
Chapter 9. Global 3D Printed Drugs Market, Regional Analysis
9.1. Global 3D Printed Drugs Market, Regional Market Snapshot
9.2. North America 3D Printed Drugs Market
9.2.1. U.S. 3D Printed Drugs Market
9.2.1.1. Technology breakdown estimates & forecasts, 2018-2028
9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
9.2.1.3. End-use breakdown estimates & forecasts, 2018-2028
9.2.2. Canada3D Printed Drugs Market
9.3. Europe 3D Printed Drugs Market Snapshot
9.3.1. U.K. 3D Printed Drugs Market
9.3.2. Germany 3D Printed Drugs Market
9.3.3. France 3D Printed Drugs Market
9.3.4. Spain 3D Printed Drugs Market
9.3.5. Italy 3D Printed Drugs Market
9.3.6. Rest of Europe3D Printed Drugs Market
9.4. Asia-Pacific 3D Printed Drugs Market Snapshot
9.4.1. China 3D Printed Drugs Market
9.4.2. India 3D Printed Drugs Market
9.4.3. Japan 3D Printed Drugs Market
9.4.4. Australia 3D Printed Drugs Market
9.4.5. South Korea 3D Printed Drugs Market
9.4.6. Rest of Asia Pacific 3D Printed Drugs Market
9.5. Latin America 3D Printed Drugs Market Snapshot
9.5.1. Brazil 3D Printed Drugs Market
9.5.2. Mexico 3D Printed Drugs Market
9.6. Rest of The World 3D Printed Drugs Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Extend Biosciences
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Application Summary
10.2.1.5. Recent Developments
10.2.2. Bioduro
10.2.3. Affinity Therapeutics
10.2.4. Osmotica Pharmaceuticals
10.2.5. Aprecia Pharmaceuticals LLC
10.2.6. GlaxoSmithKline Plc
10.2.7. FabRx Ltd
10.2.8. Hewlett Packard Caribe
10.2.9. Merck
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption